Crossmark

Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathway

Crossref DOI link: https://doi.org/10.1007/s10637-024-01501-8

Published Online: 2025-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Banchi, Marta https://orcid.org/0000-0003-0672-2066
Cox, Maria Christina

Bandini, Arianna

Orlandi, Paola

Tacchi, Costanza

Stefanelli, Fabio

Chericoni, Silvio

Bocci, Guido
Funding

Funding for this research was provided by:

Università di Pisa
License Information

Text and Data Mining valid from 2025-01-17

Version of Record valid from 2025-01-17
More Information

Article History

Received: 11 October 2024

Accepted: 30 December 2024

First Online: 17 January 2025

Declarations

:

: All authors have read and agreed to the published version of the manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below